Pyoderma gangrenosum (PG) is a chronic inflammatory neutrophilic dermatosis often presenting as a solitary enlarging painful ulcer with red to violaceous undermined borders. This report delves into the role of doxycycline in the treatment of PG in a 44-year-old male COVID-19 positive patient who has concomitant active tuberculosis infection and end-stage kidney disease, for which both first-line treatments (systemic corticosteroid and cyclosporine) are contraindicated. After three months on doxycycline and topical corticosteroids, there was resolution of the ulcers and no note of recurrence up to three months from completion of the treatment regimen.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11484569PMC
http://dx.doi.org/10.47895/amp.v58i17.7462DOI Listing

Publication Analysis

Top Keywords

doxycycline topical
8
topical corticosteroids
8
pyoderma gangrenosum
8
three months
8
combination doxycycline
4
corticosteroids treatment
4
treatment ulcerative
4
ulcerative pyoderma
4
gangrenosum case
4
case report
4

Similar Publications

This article focuses on two key innovations in dermatology: post-exposure prophylaxis for sexually transmitted infections (STIs) and new therapeutic options for inflammatory skin diseases. New European and American guidelines for doxycycline post-exposure prophylaxis (Doxy PEP) aim to prevent STIs in men who have sex with men (MSM) and individuals on HIV pre-exposure prophylaxis (PrEP). Doxy PEP is effective against syphilis and chlamydia, but its efficacy is limited by growing gonorrhea resistance.

View Article and Find Full Text PDF

Pyoderma Gangrenosum: A Nightmare for Breast Surgery-Two Case Reports.

Eur J Breast Health

January 2025

Department of General Surgery, Gülhane Training and Research Hospital, University of Health Sciences Turkey, Ankara, Turkey.

Article Synopsis
  • Pyoderma gangrenosum (PG) is a rare skin condition that causes painful ulcers and is often incorrectly diagnosed as an infection.
  • The report discusses two cases of PG following breast surgeries, where both patients initially received ineffective treatment through debridements and antibiotics.
  • Effective treatment was achieved using oral doxycycline and topical tacrolimus, highlighting the importance of early diagnosis and proper management to prevent patient suffering and disfigurement.
View Article and Find Full Text PDF

We present the case of a 36-year-old paraplegic woman with a history of spinal cord injury who developed a generalized blistering rash, later diagnosed as bullous pemphigoid (BP). During her hospitalization, she was treated with prednisone and rituximab infusions, transitioning to maintenance therapy with topical steroids, doxycycline, and nicotinamide. A year later, she presented with concerns about a BP flare on her feet.

View Article and Find Full Text PDF

Bullous pemphigoid (BP) is a chronic autoimmune disorder characterized by subepidermal blister formation, primarily affecting elderly individuals. While BP has been associated with malignancies, the exact nature of this relationship remains unclear. We report the case of a 72-year-old man who presented with pruritic cutaneous lesions, including tense vesicles and bullae and was diagnosed with BP.

View Article and Find Full Text PDF

Diagnosis of in a fledgling kererū ().

N Z Vet J

December 2024

Diagnostic and Surveillance Services, Biosecurity New Zealand, Ministry for Primary Industries, Wellington, New Zealand.

In early summer, a wild fledgling kererū () was admitted to a wildlife hospital in Dunedin after falling from its nest and being found on the ground. The bird was underweight, weighing only 391 g (expected weight > 450 g), and determined to be in poor body condition based on palpation of pectoral muscle mass. There was bilateral periorbital swelling and ocular discharge with caseous material blocking the choana.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!